comment: pembro plus chemo in neoadjuvant and adjuvant treatment for early triple-negative breas...
Published 4 years ago • 113 plays • Length 4:24Download video MP4
Download video MP3
Similar videos
-
4:54
keynote-522 updates: pembrolizumab plus neoadjuvant chemotherapy in early triple-negative breast...
-
3:09
keynote-522: neoadjuvant and adjuvant pembrolizumab for early tnbc
-
3:49
keynote-522: neoadjuvant pembro chemo vs placebo chemo, followed by adjuvant pembro vs place...
-
2:52
neoadjuvant and adjuvant therapy in triple negative breast cancer
-
5:25
neoadjuvant pembro chemo vs placebo chemo, followed by adjuvant pembro vs placebo for early-...
-
8:05
keynote-522: immune therapy and chemotherapy in patients with early triple negative breast cancer
-
7:15
pathologic complete response rates improved with the neoadjuvant and adjuvant treatment of pembr...
-
4:20
keynote 522: pembrolizumab as neoadjuvant treatment for early tnbc
-
9:02
phase 3 keynote-522 results: pembro/chemo neoadjuvant, pembro adjuvant in early tnbc
-
3:44
pembro plus chemo followed by resection and adjuvant pembro improves on soc for early nsclc
-
1:42
the case for neoadjuvant pembrolizumab in tnbc
-
4:11
asco 2020: pembrolizumab plus chemotherapy for patients with metastatic triple-negative breast c...
-
1:46
exploratory analysis of keynote-522: efs after neoadjuvant pembro chemo vs chemo for early tnbc
-
4:20
keynote-522: 5-year follow-up of pembrolizumab in triple-negative breast cancer
-
6:52
immunotherapy added to chemotherapy improves pathological complete response in early triple nega...
-
5:28
evaluating the combination of atezolizumab with neoadjuvant chemotherapy for the treatment of tr...
-
5:21
optimal neoadjuvant and adjuvant therapy for patients with early tnbc
-
1:30
keynote-355: hrqol unaffected by the addition of pembrolizumab to chemotherapy for tnbc
-
31:24
harnessing the immune system in the treatment of triple-negative breast cancer